Business Wire

CA-ANDERSEN-GLOBAL

7.10.2020 10:58:06 CEST | Business Wire | Pressemeddelelse

Del
Andersen Global indleder ekspansion på De Amerikanske Jomfruøer

Som en del af sin caribiske ekspansion, annoncerer Andersen Global sin indtræden på De Amerikanske Jomfruøer (USVI, U.S. Virgin Islands) gennem en samarbejdsaftale med advokatfirmaet Marjorie Rawls Roberts, P.C., hvilket udvider organisationens centrale dækning i regionen.

Marjorie Rawls Roberts, P.C. blev grundlagt i 1999 og har mere end 20 års erfaring med at repræsentere virksomheder og enkeltpersoner i internationale, amerikanske, samt USVI skatteanliggender og kommercielle transaktioner, privat kundepraksis, trustfonde og dødsboer, målrettede økonomiske incitamentsansøgninger og rådgivning, ejendomsanliggender og skattetvister. Firmaets advokater betjener en række indenlandske og internationale kunder, som omfatter hoteller og turistrelaterede virksomheder, servicevirksomheder, familiekontorer, teknologivirksomheder og raffinaderier. Firmaet ledes af grundlægger og administrerende partner Marjorie (Jorie) Rawls Roberts. Jorie var tidligere tilknyttet firmaet Gibson, Dunn & Crutchers afdelinger i London og Washington, D.C., og fungerede som advokatrådgiver i det amerikanske finansministeriums afdeling for skattepolitik, chefrådgiver for De Amerikanske Jomfruøers skattemyndighed, og chefrådgiver for et hedgefondforvaltningsselskab.

”Vores team er begejstret for at integrere sømløst med Andersen Globals medlemsfirmaer og samarbejdsfirmaer, samt etablere arbejdsrelationer bygget på en forbindelse gennem vores fælles værdier bestående af forvaltning og gennemsigtighed,” sagde Jorie. ”Dette samarbejde vil gøre det muligt for os at forbinde vores kunder med de bedste skatte- og juraeksperter på verdensplan og tilvejebringe oplysninger for en bredere målgruppe om de spændende investeringsmuligheder, der er tilgængelige på De Amerikanske Jomfruøer.”

”Jorie har ekstraordinære evner efter at have arbejdet for et stort advokatfirma i Washington, D.C., og tjente også som advokatrådgiver i det amerikanske finansministerium i tre år,” sagde bestyrelsesformand for Andersen Global og administrerende direktør for Andersen, Mark Vorsatz. ”De Amerikanske Jomfruøer byder på unikke muligheder for vores organisation og positionerer os yderligere til at være en one-stop-shop for vores multinationale kunder. Tilføjelsen af en placering på De Amerikanske Jomfruøer supplerer vores overordnede ekspansionsstrategi i Caribien og giver os mulighed for at levere uafhængige skatte- og juridiske tjenester af høj kvalitet til vores kunder.”

Andersen Global er en international sammenslutning af juridisk adskilte, uafhængige medlemsfirmaer bestående af skatte- og juraeksperter fra hele verden. Efter at være blevet etableret i 2013 af det amerikanske medlemsfirma Andersen Tax LLC har Andersen Global nu over 6.000 eksperter globalt og er repræsenteret på mere end 205 steder via sine medlems- og samarbejdsfirmaer.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy8.6.2026 08:00:00 CEST | Press release

Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared. "PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the leading facilities in the world," said Mark Pleško, CEO of Cosylab. "Our partners have been clear on what matters most for particle therapy: physics accuracy they can defend, clinical confidence at the point of plan approval, and a platform built to grow with AI and adaptive workflows. We designed PlanOne™ around those three priorities, and we'll keep developing it together with the clinical community that helped shape it." Physics-accurate, radiobiologically informed planning PlanOne™ is built on a GPU-accelerated Monte Carlo dose engin

BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the Region8.6.2026 06:00:00 CEST | Press release

BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA’s established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA’s Broker-Dealer license from Dubai’s Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA’s regulated product suite under VARA’s oversight, marking another step in the region’s continued buildout of institutional digital asset infrastructure amid growing demand for integrated execution and custody solutions. “The Middle East and North Africa has quickly become one of the most exciting regions in the world for digital assets, with regulators, institutions, and innovators moving with real purpose,” said Mike Bels

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release

- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye